首页> 外文期刊>American pharmaceutical review >Plastic Pre-fillable Syringes and Vials: Progress Towards a Wider Acceptance
【24h】

Plastic Pre-fillable Syringes and Vials: Progress Towards a Wider Acceptance

机译:塑料预充式注射器和小瓶:逐渐被广泛接受

获取原文
获取原文并翻译 | 示例
           

摘要

Anumber of trends can be identified in the delivery of parenteral drugs in the last decade. Amongst these is the increase in popularity and sales of pre-filled syringes, a growing availability of ready-to-fill plastic pre-fillable syringes, and the outsourcing of the final preparation of primary packaging components from the pharmaceutical companies to the component vendors. Annual global sales of pre-filled syringes are currently estimated to be over 2.2 billion globally, with over 50% of the units being supplied in nests (tubs) as ready-to-fill components [1]. Here washing, siliconization and sterilization of the components is already completed (nested) as against being supplied in bulk where these steps are the responsibility of the pharmaceutical company. In 2005, a previous article on plastic vials and plastic pre-fillable syringes reviewed the status of both their availability and interest in their use as primary packaging for parenteral products [2]. This article will examine what progress has been made in the availability of plastic pre-fillable syringes and vials, whether there has been a change in attitude of pharmaceutical companies to their use, and to review the regulation of plastics for containers.
机译:在过去的十年中,在肠胃外药物的输送中可以发现许多趋势。其中包括预灌装注射器的受欢迎程度和销售的增加,预灌装塑料预灌装注射器的可用性不断增加,以及将最终包装组件的最终制备工作从制药公司外包给组件销售商。目前,全球预填充注射器的年销售额估计超过22亿,其中超过50%的单元以预填充组件的形式在巢(桶)中提供[1]。此处,组件的清洗,硅化和灭菌已经完成(嵌套),而不是批量提供,而这些步骤是制药公司的责任。 2005年,上一篇有关塑料瓶和塑料预填充注射器的文章回顾了它们的现状以及对将其用作肠胃外产品的初级包装的兴趣[2]。本文将探讨在可预装塑料注射器和小瓶的可用性方面取得了哪些进展,制药公司对它们的使用态度是否发生了变化,并回顾了用于容器的塑料的法规。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号